Kyowa Hakko 32024

March 31, 2003

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal


Kyowa Hakko

NEW YORK--Kyowa Hakko U.S.A. offers Citicoline, analternative to phosphatidylcholine, that can be used to promote brain function.Kyowa Hakko (www.kyowa.com) developed newcommercial production techniques of Citicoline using fermentation technology.The company added there are extensive studies showing Citicoline crosses theblood-brain barrier and is incorporated into brain membrane lipids, and that itmay be effective in treating Alzheimer's disease, Parkinson's disease andglaucoma.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like